logo

For the Inventor, By the Inventor

San Jose, CA, United States of America

Ruby Yanru Tsai

This inventor holds 12 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Applied Stemcell, Inc., Asc Therapeutics Inc., Leland Stanford Junior University. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruby Yanru Tsai. Retrieved from https://idiyas.com/inventor/ruby-yanru-tsai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal8 out of 9 
 
Applied Stemcell, Inc.
 patents
silverMedal2 out of 2 
 
Asc Therapeutics Inc.
 patents
bronzeMedal2 out of 5,519 
 
Leland Stanford Junior University
 patents
4. 1 out of 3,546 
 
University of Michigan
 patents
where one patent can have more than one assignee

Years Active: 2015-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12485143 - HLA-F-MODIFIED CELLS AND METHODS (2025-12-02),
2. 12291706 - Methods for screening variant of target gene (2025-05-06),
3. 12076346 - HLA-F-modified cells and methods (2024-09-03),
4. 11981898 - Gene editing methods with increased knock-in efficiency (2024-05-14),
5. 11959093 - Integration sites and uses thereof (2024-04-16),
6. 11647737 - Genetically modified rabbit expressing an exogenous protein in milk (2023-05-16),
7. 11597947 - Gene editing method using virus (2023-03-07),
8. 11505792 - Site-specific integration of transgenes (2022-11-22),
9. 11492613 - Methods for screening variant of target gene (2022-11-08),
10. 11339408 - Nuclease with enhanced efficiency of genome editing (2022-05-24),
11. 9932607 - Site-specific integration of transgenes into human cells (2018-04-03),
12. 9125385 - Site-directed integration of transgenes in mammals (2015-09-08),

Title: Ruby Yanru Tsai: Innovator in Genetic Screening and Cell Therapy

Introduction

Ruby Yanru Tsai is a prominent inventor based in San Jose, California. She has made significant contributions to the fields of genetic screening and cell transplantation therapy. With a total of 11 patents to her name, her work has advanced the understanding and application of genetic technologies.

Latest Patents

Among her latest patents are innovative methods for screening variants of target genes. These methods provide a framework for identifying desired variants in a eukaryotic system. Additionally, she has developed compositions for screening these variants. Another notable patent involves HLA-F-modified cells and methods, which focus on cell transplantation therapy. This patent details the forced expression of an exogenous HLA-F protein in donor cells, enhancing their compatibility for transplantation.

Career Highlights

Ruby has worked with esteemed organizations such as Applied Stemcell, Inc. and Leland Stanford Junior University. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Alfonso Farruggio and Ling-Jie Kong. Their collaborative efforts have furthered the impact of her inventions and research.

Conclusion

Ruby Yanru Tsai's innovative work in genetic screening and cell therapy exemplifies her dedication to advancing medical science. Her patents reflect her commitment to improving healthcare through technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…